SHELBY PAWLOWSKI: Open Payments
NPI 1063180008 · MURFREESBORO, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$566 in 28 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $570 · 2025 $566
Food & beverage: $566
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 4 | $110 |
| Otsuka America Pharmaceutical, Inc. | 5 | $103 |
| Exact Sciences Corporation | 5 | $82 |
| GlaxoSmithKline, LLC. | 4 | $82 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $57 |
| Novo Nordisk Inc | 3 | $57 |
| Lilly USA, LLC | 3 | $56 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $19 |
Products named: Veozah, REXULTI, Cologuard Collection Kit, SHINGRIX, Kerendia, MOUNJARO, Rybelsus, CAPLYTA.
Industry payments across TN — which companies pay providers there.
